Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epithelial-Mesenchymal Transition”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Not applicableUnknownNCT05995067
What this trial is testing

The Potential Association of Long Non-coding RNA (NEAT1 and MALAT1) in the Process of Epithelial-mesenchymal Transition in Periodontitis

Who this might be right for
Periodontal Disease, AVDC Stage 3and 4Epithelial Mesenchymal TransitionLong Noncoding RNA
Ali A Abdulkareem 48
Early research (Phase 1)Looking for participantsNCT06147037
What this trial is testing

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorMetastatic Colorectal CarcinomaHead and Neck Squamous Cell Carcinoma+4 more
AstraZeneca 70
Testing effectiveness (Phase 2)Ended earlyNCT04515394
What this trial is testing

Study of Tepotinib Combined With Cetuximab in Participants With Left-Sided RAS/BRAF Wild Type Metastatic Colorectal Cancer (PERSPECTIVE)

Who this might be right for
Colorectal Neoplasms
EMD Serono Research & Development Institute, Inc. 3
Not applicableUnknownNCT01927354
What this trial is testing

Study on the Interplay Between Twist1 and Other EMT Regulators Through microRNA-29 Family.

Who this might be right for
Head-and-Neck Squamous Cell Carcinoma
National Taiwan University Hospital 100
Early research (Phase 1)Ended earlyNCT04982224
What this trial is testing

Study of REGN5093-M114 (METxMET Antibody-Drug Conjugate) in Adult Patients With Mesenchymal Epithelial Transition Factor (MET) Overexpressing Advanced Cancer

Who this might be right for
Advanced NSCLC
Regeneron Pharmaceuticals 30
Post-approval studies (Phase 4)UnknownNCT01111422
What this trial is testing

Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients

Who this might be right for
End-Stage Kidney DiseasePeritoneal Dialysis
Ewha Womans University 66
Testing effectiveness (Phase 2)Looking for participantsNCT05550415
What this trial is testing

The Role of Simvastatin in the Epithelial-Mesenchymal Transition Process of Breast Cancer

Who this might be right for
Triple Negative Breast CancerChemotherapy EffectSimvastatin Adverse Reaction
Indonesia University 26
Not applicableUnknownNCT04323917
What this trial is testing

Detection of High Expression Levels of EMT-Transcription Factor mRNAs in Patients With Pancreatic Cancer and Their Diagnostic Potential

Who this might be right for
Pancreatic Cancer
Istituto Clinico Humanitas 850
Early research (Phase 1)Not Yet RecruitingNCT05940116
What this trial is testing

A Phase I Clinical Study of HS-20117 in Participants With Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerSolid Tumor
Hansoh BioMedical R&D Company 322
Not applicableUnknownNCT05403164
What this trial is testing

Epithelial Mesenchymal Transition and Periodontitis

Who this might be right for
PeriodontitisPeriodontal DiseasesEpithelial-Mesenchymal Transition+3 more
University of Baghdad 80
Early research (Phase 1)Study completedNCT02412462
What this trial is testing

Phase I Dose Escalation Study of AB-16B5 in Subjects With an Advanced Solid Malignancy

Who this might be right for
Solid TumorMetastatic Cancer
Alethia Biotherapeutics 15
Early research (Phase 1)Study completedNCT03030417
What this trial is testing

Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas

Who this might be right for
Solid TumorsLymphoma
National Cancer Institute (NCI) 36
Not applicableUnknownNCT04323813
What this trial is testing

"High Levels of EMT-TFs for the Diagnosis of Colorectal Cancer (CRC)"

Who this might be right for
Colorectal Cancer
Istituto Clinico Humanitas 900
Not applicableStudy completedNCT04137523
What this trial is testing

Investigate eNAMPT in Multiple Myeloma Biology and Establish Its Role in Disease Progression

Who this might be right for
Multiple Myeloma
University of Turin, Italy 26
Not applicableNot Yet RecruitingNCT07529639
What this trial is testing

Tumor Budding and T1 Substaging in Urothelial Bladder Cancer

Who this might be right for
Urothelial Bladder CarcinomaBladder CarcinomaNon-Muscle-Invasive Bladder Cancer (NMIBC)+1 more
Assiut University 100
Not applicableUnknownNCT02940977
What this trial is testing

Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection Technique

Who this might be right for
Prostatic NeoplasmsProstatic Adenoma
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 120
Not applicableUnknownNCT04137406
What this trial is testing

Role of SIRT1 in Regulation of Epithelial-to-mesenchymal Transition in Breast Cancer Lymph Nodes Metastasis

Who this might be right for
Breast CancerLymph Node Metastases
Peking University People's Hospital 160
Not applicableWithdrawnNCT02022904
What this trial is testing

Prostate Cancer Circulating Tumor Cells Based on Epithelial-Mesenchymal Transition Biology

Who this might be right for
Prostate Cancer
Duke University
Not applicableStudy completedNCT04817501
What this trial is testing

Phenotypic Spectrum of CTCs in Tumors of the Female Reproductive System

Who this might be right for
Breast CancerOvarian CancerEndometrial Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences 150
Early research (Phase 1)Looking for participantsNCT07181681
What this trial is testing

A First-in-Human Study of BG-C0902 Alone and in Combination With Other Therapeutic Agents in Patients With Advanced Solid Tumors

Who this might be right for
Solid TumorsAdvanced Solid Tumor
BeOne Medicines 63
Load More Results